Market opportunity Target research labs and early adopters in genomics sequencing who are looking to reduce costs and increase speed; position Quantapore as a lower‑cost nanopore sequencing solution with rapid deployment through on‑site unit seeding and consumables.

Funding credibility Leverage recent Series 3 funding and notable board member addition to engage investors and strategic partners, using the momentum to open discussions with potential distributors, research institutions, and hospital genomics centers seeking innovative platforms.

Technical edge Highlight proprietary optically labeled nanopore technology and single‑molecule sequencing capability as a differentiator for fast, affordable whole-genome sequencing, targeting customers expanding from traditional platforms.

Expansion signals Capitalize on the planned growth trajectory from equipment and consumables sales driven by a growing installed base; pursue multi‑year procurement deals with institutions that want scalable sequencing capacity and consumable streams.

Competitive landscape Map against peers like Oxford Nanopore and 10x Genomics to identify gaps in throughput, cost per run, and service models; tailor sales outreach to labs seeking flexible, desktop‑scale sequencing with consumable revenue models.